Neurotech International Future Growth
Future criteria checks 2/6
Neurotech International is forecast to grow earnings and revenue by 33.6% and 44.7% per annum respectively. EPS is expected to decline by 90.1% per annum. Return on equity is forecast to be -45% in 3 years.
Key information
33.6%
Earnings growth rate
-90.1%
EPS growth rate
| Medical Equipment earnings growth | 16.3% |
| Revenue growth rate | 44.7% |
| Future return on equity | -45.0% |
| Analyst coverage | Low |
| Last updated | 16 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Why Neurotech International Limited (ASX:NTI) Could Be Worth Watching
Nov 19
Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans
Sep 19Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
Jan 28We Think Neurotech International (ASX:NTI) Needs To Drive Business Growth Carefully
Oct 14Here's Why We're Not Too Worried About Neurotech International's (ASX:NTI) Cash Burn Situation
Jul 01Is Neurotech International (ASX:NTI) In A Good Position To Invest In Growth?
Jan 21Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?
Oct 06Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
May 18We're Not Very Worried About Neurotech International's (ASX:NTI) Cash Burn Rate
Dec 21Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans
Sep 04Need To Know: Neurotech International Limited (ASX:NTI) Insiders Have Been Selling Shares
Dec 08
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | 3 | -7 | -8 | -8 | 1 |
| 6/30/2026 | 3 | -6 | -6 | -6 | 1 |
| 6/30/2025 | 2 | -6 | -6 | -6 | 1 |
| 6/30/2024 | 3 | -5 | -5 | -5 | N/A |
| 3/31/2024 | 3 | -5 | -4 | -4 | N/A |
| 12/31/2023 | 3 | -5 | -4 | -4 | N/A |
| 9/30/2023 | 2 | -6 | -5 | -5 | N/A |
| 6/30/2023 | 1 | -8 | -6 | -6 | N/A |
| 3/31/2023 | 1 | -6 | -5 | -5 | N/A |
| 12/31/2022 | 2 | -5 | -4 | -4 | N/A |
| 9/30/2022 | 1 | -4 | -4 | -4 | N/A |
| 6/30/2022 | 1 | -3 | -3 | -3 | N/A |
| 3/31/2022 | 0 | -4 | -3 | -3 | N/A |
| 12/31/2021 | 0 | -6 | -3 | -3 | N/A |
| 9/30/2021 | 0 | -7 | -3 | -3 | N/A |
| 6/30/2021 | 0 | -7 | -2 | -2 | N/A |
| 3/31/2021 | 0 | -6 | -2 | -2 | N/A |
| 12/31/2020 | 0 | -5 | -1 | -1 | N/A |
| 9/30/2020 | 0 | -3 | -1 | -1 | N/A |
| 6/30/2020 | 0 | -2 | -1 | -1 | N/A |
| 3/31/2020 | 0 | -3 | -1 | -1 | N/A |
| 12/31/2019 | 0 | -4 | -1 | -1 | N/A |
| 9/30/2019 | 0 | -4 | -2 | -2 | N/A |
| 6/30/2019 | 0 | -5 | -3 | -3 | N/A |
| 3/31/2019 | 0 | -4 | -3 | -3 | N/A |
| 12/31/2018 | 0 | -4 | -4 | -3 | N/A |
| 9/30/2018 | 0 | -4 | -4 | -3 | N/A |
| 6/30/2018 | 0 | -4 | -4 | -3 | N/A |
| 3/31/2018 | 0 | -4 | N/A | -3 | N/A |
| 12/31/2017 | 0 | -4 | N/A | -3 | N/A |
| 9/30/2017 | 0 | -4 | N/A | -3 | N/A |
| 6/30/2017 | 0 | -4 | N/A | -3 | N/A |
| 12/31/2016 | 0 | -4 | N/A | -3 | N/A |
| 9/30/2016 | 0 | -4 | N/A | -2 | N/A |
| 6/30/2016 | 0 | -3 | N/A | -2 | N/A |
| 12/31/2015 | 0 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NTI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NTI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NTI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NTI's revenue (44.7% per year) is forecast to grow faster than the Australian market (5.8% per year).
High Growth Revenue: NTI's revenue (44.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NTI is forecast to be unprofitable in 3 years.